FDA's Treatment IND: Good News or Bad News for Cancer Care?
作者:
MannistoMarilyn M.,
期刊:
The Journal of Cancer Program Management
(Taylor Available online 1988)
卷期:
Volume 3,
issue 2
页码: 24-27
ISSN:0898-6053
年代: 1988
DOI:10.1080/08986053.1988.11904929
出版商: Taylor&Francis
数据来源: Taylor
摘要:
Summary:Many providers believe the FDA's new“fast track”approval process for experimental drugs—treatment IND—is a step in the right direction, but participants at a recent AMA-FDA conference raised serious questions about such issues as payment, access, liability, and the effect on clinical trials.
点击下载:
PDF (5954KB)
返 回